By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile



Corporate Headquarters
One Amgen Center Drive
Thousand Oaks  California  91320-1789  U.S.A.
Phone: 805-447-1000 Fax: 805-447-1010



Genesis Research and Development Corporation 

Phylos, Inc.  In 2000, Phylos entered into collaboration with Amgen to apply Phylos' PROfusion™ technology to rapidly identify high-affinity binding agents to potential therapeutic targets supplied by Amgen. Amgen will use the sequences and structural information gained through this collaboration for its internal drug discovery programs.

UCB, Inc.  Contract manufacturing of Abarelix peptide active ingredient

EPIX Pharmaceuticals, Inc. 

Dyax Corp.  Antibody phage display

Company News
Amgen (AMGN) Announces Appointment Of R. Sanders Williams To Board Of Directors 10/20/2014 7:48:38 AM
Amgen (AMGN) Announces 2014 Fourth Quarter Dividend 10/20/2014 7:47:30 AM
Amgen (AMGN) Will Assign 12 To 14 Staff Members To Look Into An Alternative Production Method For Mapp Biopharmaceutical's ZMapp 10/20/2014 5:13:30 AM
Amgen (AMGN) Files Lawsuit Against Sanofi (SAN.PA) And Regeneron (REGN) For Patent Infringement 10/17/2014 7:47:29 AM
Amgen (AMGN)'s Leukemia Drug Blinatumomab Gets FDA Priority Review 10/10/2014 5:55:07 AM
Amgen (AMGN)'s ABP 501 Met Primary Endpoint In Phase 3 Psoriasis Study 10/8/2014 7:39:02 AM
What Seattle Needs: Dealing With Amgen (AMGN)'s Upcoming Departure 10/7/2014 6:16:19 AM
Amgen (AMGN) Release: The Lancet Publishes Two Phase 3 Studies Showing Cholesterol-Lowering Medication Evolocumab Significantly Reduced LDL Cholesterol In Patients With Serious Genetic Disorders That Cause High Cholesterol 10/2/2014 8:12:30 AM
Amgen (AMGN) Announces Moderate-To-Severe Plaque Psoriasis Data To Be Presented At The 23rd Congress Of The European Academy Of Dermatology And Venereology 10/2/2014 8:08:35 AM
Amgen (AMGN) To Host Summary Webcast Of Kyprolis® (Carfilzomib) For Injection Data Presented At The European Society For Medical Oncology (ESMO) 2014 Congress 9/25/2014 7:55:23 AM